An <i>in situ</i> spontaneously forming micelle-hydrogel system with programmable release for the sequential therapy of anaplastic thyroid cancer-Reference-Cited by-同舟云学术

An in situ spontaneously forming micelle-hydrogel system with programmable release for the sequential therapy of anaplastic thyroid cancer

Published:2022 Issue:8 Volume:10 Page:1236-1249
ISSN:2050-750X
Container-title:Journal of Materials Chemistry B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Yang Xi¹,Zhang Lingyun²³,Zheng Lingnan¹,Wang Yan⁴,Gao Ling¹,Luo Rui⁴,Li Xinchao⁴,Gong Changyang⁴^ORCID,Luo Han²,Wu Qinjie⁴

Affiliation:

1. Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, P. R. China

2. Department of Thyroid and Parathyroid Surgery, Laboratory of Thyroid and Parathyroid Disease, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu 610041, P. R. China

3. West China School of Medicine, Sichuan University, Chengdu 610041, P. R. China

4. State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, P. R. China

Abstract

An in situ spontaneously forming micelle-hydrogel system was developed for localized sequential chemotherapy; it released drugs programmatically and exerted remarkable anti-tumor efficacy.

Funder

China Postdoctoral Science Foundation

National Natural Science Foundation of China

Sichuan University

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering,General Chemistry,General Medicine

Link

http://pubs.rsc.org/en/content/articlepdf/2022/TB/D1TB01904J

Reference42 articles.

1. 2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer